Primary Site >> Esophagus Cancer

Gene >> SLC14A2

  • 1995
  • 1997
  • 2011
  • 2012
  • 2013
  • 2015
  • 2017
  • 2018
Ref: Long-term survival after photodynamic therapy for esophageal cancer.
PMID: 7835574
 Ref: Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer.
PMID: 9255531
Ref: Interobserver agreement in the staging of rectal cancer using endoscopic ultrasonography.
PMID: 9360871
 Ref: Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
PMID: 21170987
 Ref: Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.
PMID: 21990000
 Ref: Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
PMID: 23933602
 Ref: Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection.
PMID: 26233274
Ref: Regulation of beta-catenin-mediated esophageal cancer growth and invasion by miR-214.
PMID: 26807179
 Ref: miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42.
PMID: 28393193
 Ref: MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
PMID: 29094237
Ref: MiR-149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase beta.
PMID: 29726631